Antibacterial effect of etoposide in vitro
- 1 September 1988
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 32 (9) , 1456-1457
- https://doi.org/10.1128/aac.32.9.1456
Abstract
Etoposide, an antitumor drug, had an effect in vitro against all strains of gram-positive bacteria studied but not against three gram-negative bacteria. The MICs ranged between 6.2 and 50 .mu.g/ml. In short-term-growth experiments, etoposide had a bactericidal efficacy that was 10 to 50 times lower than that of cloxacillin.This publication has 12 references indexed in Scilit:
- Etoposide (VP-16–213)New England Journal of Medicine, 1985
- EFFECTS OF THE EPIPODOPHYLLOTOXIN VP-16-213 ON CELL-CYCLE TRAVERSE, DNA-SYNTHESIS, AND DNA STRAND SIZE IN CULTURES OF HUMAN-LEUKEMIC LYMPHOBLASTS1983
- Standardization of Antibiotic Sensitivity TestsScandinavian Journal of Infectious Diseases, 1982
- Pharmacokinetics of VP16-213 given by different administration methodsCancer Chemotherapy and Pharmacology, 1982
- Pharmacokinetics of VP16-213 in Lewis lung carcinoma bearing miceCancer Chemotherapy and Pharmacology, 1982
- VP16-213 (etoposide). A critical review of its activity.1982
- The Relative Potency of Amoxycillin and Ampicillin in Vitro and in VivoScandinavian Journal of Infectious Diseases, 1981
- Cefazolin and Cephradine: Relationship between Antibacterial Activity in Vitro and in Mice Experimentally Infected with Escherichia coliThe Journal of Infectious Diseases, 1978
- Effect of VP-16-213 on the intracellular degradation of DNA in HeLa cellsBiochemistry, 1976
- Cloxacillin and Nafcillin: Serum Binding and Its Relationship to Antibacterial Effect in MiceThe Journal of Infectious Diseases, 1973